Top Industry Stories – July 23, 2009 « Medical Dynamics

THE LATEST WORD

Top Industry Stories – July 23, 2009

Posted on July 23rd, 2009 | by Rxmedyn | No Comments »

“After Medarex buy, biotech investors ask who’s next” (Reuters)
“Abraxis BioScience Announces Date for 2009 Second Quarter Financial Results and Investor Conference Call” (Press release issued by Abraxis BioScience, Business Wire)
“More Than 500 Philadelphia Youth with Asthma and Their Families to Attend Keystone Mercy Healthy Hoops Program” (Press release issued by Keystone Mercy, PRWeb)
“Alcon strikes drug development deal with AstraZeneca, announces second-quarter results” (OSN Supersite)
“Cell Therapeutics prices stock and warrant offer” (The Associated Press)
“FDA Approves Expanded Use of Lilly’s FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis” (Press release issued by Eli Lilly and Co, PRNewswire)
“Swine flu vaccine poses problem for makers-US FDA” (Reuters)
“Swine flu a bonus for Glaxo’s Relenza flu drug” (Reuters)
“Physicians Interactive Acquires Skyscape Inc.– Becoming World’s Leading Mobile Medical Information Provider” (Press release issued by Physician’s Interactive, PRNewswire)
“Teva, Taro lobby US legislators on biogenerics” (Globes)
“FDA Faults Cytogam Sales Literature For Unsubstantiated Long-Term Survival Claim” (The Pink Sheet)
“Allergan Receives FDA Approval for ACUVAIL(TM) Ophthalmic Solution for the Treatment of Pain and Inflammation Following Cataract Surgery” (Press release issued by Allergan, Business Wire)
“Bristol-Myers to buy Medarex for $2.4 billion” (Reuters)
“Earnings Top Forecasts at 3 Drug Makers” (The New York Times)
“Alcon Q2 Profit Rises, Beats Estimates; Lifts FY09 Forecast – Update” (RTTNews)
“Bristol Myers, Wyeth Post Higher Profit” (Wall Street Journal)
“AstraZeneca Expands Prescription Savings Program” (Press release issued by AstraZeneca, PRNewswire)
“Researchers to implant pig cells in diabetics” (Reuters)
“Biocon Net Profit Soars” (Wall Street Journal)
“A Time for Revolutions — The Role of Clinicians in Health Care Reform” (NEJM)
“Roche Ups Guidance Amid Genentech, Tamiflu Boost” (Wall Street Journal)

Posted in Industry Stories

Leave a Reply

You must be logged in to post a comment.